Chondrial Therapeutics' Unattributed Round

Chondrial Therapeutics raised a round of funding on August 13, 2014.

Chondrial Therapeutics is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases. Chondrial's lead compound is CTI-1601, which the Company is developing as a potenti…

Articles about Chondrial Therapeutics' Unattributed Round: